Pediatric breast cancer rates are low, but guidelines exist to help alleviate patient concerns.
Roughly 12% of women will receive a breast cancer diagnosis in their lifetimes. Only 1% of men will get the same news. Even fewer children-less than 1/100th a percent-develop the condition.
But, thanks to breast cancer awareness campaigns, alertness and anxiety surrounding this disease continue to grow, including among parents. Their concern when a suspicious finding appears in a diagnostic screening test makes it critical that you understand whether and how to use breast ultrasound in such a young population. It can be a useful tool in identifying any abnormality in pediatric breast tissue.
To devise how best to tackle this issue, the University of California at Los Angeles (UCLA) and Children’s Hospital Los Angeles collaborated to improve pediatric breast ultrasound reporting and recommendations. They conducted a literature review to identify best practices in pediatric breast ultrasound, and they reviewed the final pathology reports from 76 pediatric breast ultrasounds performed within their institution.
Their results were published in a 2017 Journal of the American College of Radiology article. Prior to their publication, no formalized guidelines for using breast ultrasound in the pediatric population existed. The team defined pediatric population as any patient under the age of 21.
“We created standardized recommendations for common breast ultrasound findings in the pediatric population based on the results of our literature search for best practices,” wrote Aarti Luhar, MD lead study author and diagnostic and interventional radiologist with UCLA Medical Center. “We believe that offering consistent, specific recommendations will help decrease unnecessary follow-up for pediatric patients.”
Related article: Physical Exam Not Augmented by Breast Ultrasound in Younger Women
The drafted recommendations were reviewed by a multi-disciplinary board, including a board certified pediatric radiologist, a board-certified breast-imaging radiologist, and a board-certified pediatric surgeon.
In the pediatric population, breast ultrasound is the preferred screening modality for a variety of reasons. Not only does it provide adequate screening for dense breast tissue, but it doesn’t expose children to ionizing radiation that could harm immature glandular tissue like a mammogram or tomosynthesis would. And while an MRI doesn’t introduce radiation, children frequently must be sedated to undergo the procedure, making it neither time- nor cost-effective.
According to Luhar’s study team, BI-RADS shouldn’t be used to report findings in the pediatric population because the classification system overstates the risks of malignancy, particularly for categories 3 and 4.
All total, the team drafted seven recommendations based both on age and clinical finding.
Overall, Luhar says, specific recommendations could decrease any prolonged imaging or procedural work-up. As a result, patient and parent anxiety could fall, and cost savings could be generated by avoiding unneeded, additional imaging.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.